- Trials with a EudraCT protocol (16)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
16 result(s) found for: Epidemiological data.
Displaying page 1 of 1.
EudraCT Number: 2014-001290-14 | Sponsor Protocol Number: EMR200136_583 | Start Date*: 2014-10-24 |
Sponsor Name:MERCK ROMANIA SRL | ||
Full Title: Prospective Phase IV Clinical Trial on Effectiveness of Rebif Treatment of CIS and RMS Patients in Romania using Electronic Device RebiSmart™ | ||
Medical condition: Clinical isolated syndrome and relapse multiple sclerosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: RO (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-002890-37 | Sponsor Protocol Number: 1 | Start Date*: 2017-02-07 | |||||||||||
Sponsor Name:Esther Aleo Lujan | |||||||||||||
Full Title: Double-blind randomized clinical trial to compare presurgery anxiolysis in children treated with hydroxyzine versus non-pharmacological intervention (distractoria technique clown). | |||||||||||||
Medical condition: Presurgery anxiety | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-001791-20 | Sponsor Protocol Number: MEPOCHUSS (protocol version 1.2) | Start Date*: 2008-06-30 | |||||||||||
Sponsor Name:University Hospital of Schleswig-Holstein (UKSH), Campus Lübeck | |||||||||||||
Full Title: A Phase II, single center open label, prospective trial to evaluate the efficacy and safety of mepolizumab for patients with refractory or relapsing Churg Strauss Syndrome | |||||||||||||
Medical condition: Churg-Strauss-Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001031-27 | Sponsor Protocol Number: CQ4COV19 | Start Date*: 2020-03-14 | ||||||||||||||||
Sponsor Name:FUNDACIÓN FLS DE LUCHA CONTRA EL SIDA, LAS ENFERMEDADES INFECCIOSAS Y LA PROMOCIÓN DE LA SALUD Y LA CIENCIA | ||||||||||||||||||
Full Title: Treatment of non-severe confirmed cases of COVID-19 and chemoprophylaxis of their contacts as prevention strategy: a Cluster Randomized Clinical Trial (PEP CoV-2 Study) | ||||||||||||||||||
Medical condition: SARS-CoV-2 Respiratory Viral Infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-017063-42 | Sponsor Protocol Number: ML22606 | Start Date*: 2010-12-07 |
Sponsor Name:Roche Romania SRL | ||
Full Title: Biomarkers Impact On the response to Treatment with Erlotinib in first line non-small cell lung Cancer with EGFR activating mutations | ||
Medical condition: Non-small cell lung cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: RO (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-002144-23 | Sponsor Protocol Number: 2020_TRANEXAMICO | Start Date*: 2022-03-18 |
Sponsor Name:Asociación Instituto Biodonostia | ||
Full Title: Randomized, double-blind clinical trial to assess the efficacy of tranexamic acid in reducing blood loss in patients with hip fracture | ||
Medical condition: Hip fracture. | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-005262-35 | Sponsor Protocol Number: 16401 | Start Date*: 2013-07-08 | ||||||||||||||||
Sponsor Name:Bayer HealthCare AG | ||||||||||||||||||
Full Title: BENEFIT 11 a long-term, follow-up study (16401) of the BENEFIT (304747), BENEFIT Follow-up (305207) Studies and BENEFIT Extension (311129) Study to further evaluate the progress of patients with fi... | ||||||||||||||||||
Medical condition: Clinically isolated syndrome (CIS) and multiple sclerosis (MS) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) SE (Completed) PT (Completed) HU (Completed) CZ (Completed) NO (Completed) AT (Completed) FI (Completed) DK (Completed) GB (Completed) ES (Completed) IT (Completed) SI (Completed) PL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-000730-30 | Sponsor Protocol Number: R1788 | Start Date*: 2015-05-21 |
Sponsor Name:Hull and East Yorkshire Hospitals NHS Trust | ||
Full Title: A randomised clinical trial comparing endovenous laser ablation and mechanochemical ablation (ClariVein®) in the management of superficial venous insufficiency. | ||
Medical condition: Varicose veins (VVs) or Superficial Venous Insufficiency (SVI) of the legs results from inflammation mediated damage to vein structure, allowing reverse flow. SVI affects 30% of adults and is assoc... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2015-000699-91 | Sponsor Protocol Number: RACHE | Start Date*: 2015-09-14 | |||||||||||
Sponsor Name:Fundació Hospital Vall Hebron Institut de Recerca | |||||||||||||
Full Title: Two treatment strategies with Ribavirin for Chronic Hepatitis E and severe acute forms randomized study | |||||||||||||
Medical condition: Chronic Hepatitis E | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001505-22 | Sponsor Protocol Number: BST-COVID-01 | Start Date*: 2020-04-23 | |||||||||||
Sponsor Name:Banc de Sang i Teixits | |||||||||||||
Full Title: Double-blind, randomized, parallel, placebo-controlled pilot clinical trial, nested in a prospective cohort observational study, for the evaluation of the efficacy and safetyof two doses of WJ-MSC ... | |||||||||||||
Medical condition: Acute respiratory distress syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000282-20 | Sponsor Protocol Number: 109069 | Start Date*: 2012-04-12 | |||||||||||
Sponsor Name:GlaxoSmithKline Biologicals | |||||||||||||
Full Title: A phase III, randomized, open, controlled, multicenter primary vaccination study to demonstrate the non inferiority of the immunogenicity of meningococcal vaccine GSK134612 given intramuscularly ve... | |||||||||||||
Medical condition: Meningococcal disease | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000283-23 | Sponsor Protocol Number: 109495 | Start Date*: 2012-04-12 | |||||||||||
Sponsor Name:GlaxoSmithKline Biologicals | |||||||||||||
Full Title: A phase III, open, randomized, controlled primary vaccination study to demonstrate the non-inferiority of meningococcal vaccine GSK134612 given intramuscularly versus Mencevax™ ACWY given subcutane... | |||||||||||||
Medical condition: Meningococcal disease | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-002764-79 | Sponsor Protocol Number: RESCUE | Start Date*: 2023-04-13 | |||||||||||
Sponsor Name:Fundació Clínic per a la Recerca Biomèdica | |||||||||||||
Full Title: Diagnostic yield of Endoscopic aspiration of duodenopancreatic juice after secretin stimulation (ADPJ-secr-) vs endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for molecular analysis ... | |||||||||||||
Medical condition: Intraductal papillary mucinous intraductal neoplasia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003587-36 | Sponsor Protocol Number: 684/MODREC/15 | Start Date*: 2016-04-13 | ||||||||||||||||
Sponsor Name:Directorate of Defence Rehabilitation | ||||||||||||||||||
Full Title: Chronic Tendinopathy: The Biomechanical Associations and EfFicacy of Injectable Therapy (BE FIT) Study | ||||||||||||||||||
Medical condition: Chronic degenerative Achilles and patella tendinopathy patients, with neovascularisation on USS, who have failed best practice rehabilitation including Eccentric Loading (EL), Heavy Slow Resistance... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-001290-17 | Sponsor Protocol Number: F901318/0032 | Start Date*: 2018-03-30 |
Sponsor Name:F2G Biotech GmbH (FN 483749 x) | ||
Full Title: An open-label single-arm Phase IIb study of F901318 as treatment of invasive fungal infections due to Lomentospora prolificans, Scedosporium spp., Aspergillus spp., and other resistant fungi in pat... | ||
Medical condition: invasive fungal infections due to Lomentospora prolificans, Scedosporium spp., Aspergillus spp., and other resistant fungi | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) ES (Ongoing) NL (Completed) DE (Completed) GB (GB - no longer in EU/EEA) PL (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-000450-21 | Sponsor Protocol Number: MONS4STRAT | Start Date*: 2018-04-09 |
Sponsor Name:Fundación Investigación Biomédica Hospital Ramón y Cajal | ||
Full Title: Prospective, Randomized, Open, Controlled, Multicenter Study to Evaluate the Safety and Efficacy of the MON4STRAT Approach for Optimizing Meropenem Therapy in Intubated and Mechanically-Ventilated,... | ||
Medical condition: Nosocomial pneumonia or severe tracheobronchitis caused by Gram-negative pathogens in subjects that requiring mechanical ventilation. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) FR (Prematurely Ended) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
